test

Nir Messafi

@Deep Track Capital, Lp

Latest period2024 - Q3ReportedManaged Assets$3.153BTotal holdings69
Assets growth rate-5.9%Assets growth rate (2-Q avg)-4.96%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Deep Track Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Deep Track Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.153B in assets, with a quarterly growth rate of -5.9% and a 2-quarter average growth rate of -4.96%. The portfolio is managed by Nir Messafi, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ALKSAlkermes Plc
Recent Activity
3.11%
$97.965M
3.5M shares@ $27.99 avg price
AXSMAxsome Therapeutics Inc
Recent Activity
Decreased -42.93%
3.02%
$95.012M↑ Call
1.057M shares@ $89.88 avg price
VRNAVerona Pharma Plc
Recent Activity
Decreased -20.49%
2.91%
$91.489M
3.18M shares@ $28.77 avg price
IONSIonis Pharmaceuticals Inc
Recent Activity
Increased 10%
2.8%
$88.132M
2.2M shares@ $40.06 avg price
NRIXNurix Therapeutics Inc
Recent Activity
Decreased -3.09%
2.76%
$86.916M
3.868M shares@ $22.48 avg price
VRDNViridian Therapeutics Inc
Recent Activity
Decreased -4.4%
2.71%
$85.334M
3.751M shares@ $22.76 avg price
BCYCBicycle Therapeutics Plc
Recent Activity
Increased 1.65%
2.55%
$80.291M
3.548M shares@ $22.64 avg price
MBXMbx Biosciences Inc
Recent Activity
New Position
2.49%
$78.432M
3.019M shares@ $25.98 avg price
PLRXPliant Therapeutics Inc
Recent Activity
2.13%
$66.949M
5.972M shares@ $11.22 avg price
APGEApogee Therapeutics Inc
Recent Activity
1.87%
$58.74M
1M shares@ $58.74 avg price